Silence Therapeutics PLC (SLN)

NASDAQ: SLN · IEX Real-Time Price · USD
19.95
1.24 (6.63%)
At close: Jan 21, 2022 4:00 PM
19.58
-0.37 (-1.85%)
After-hours:Jan 21, 2022 4:00 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202020192018
Revenue
5.480.240
Revenue Growth (YoY)
2145.49%--
Cost of Revenue
3.7600
Gross Profit
1.720.240
Selling, General & Admin
13.989.6410.83
Research & Development
20.2113.349.74
Other Operating Expenses
3.370-0.01
Operating Expenses
37.5622.9820.57
Operating Income
-35.85-22.73-20.57
Interest Expense / Income
0.320.160
Other Expense / Income
-0.13-0.03-0.04
Pretax Income
-36.04-22.87-20.53
Income Tax
-3.49-3.29-2.12
Net Income
-32.55-19.58-18.41
Net Income Common
-32.55-19.58-18.41
Shares Outstanding (Basic)
7878-
EPS (Basic)
--0.78-0.78
EPS (Diluted)
--0.78-0.78
Free Cash Flow Per Share
-0.430.07-
Gross Margin
31.34%100.00%-
Operating Margin
-654.26%-9317.21%-
Profit Margin
-594.03%-8025.41%-
Free Cash Flow Margin
-205.95%704.10%-
Effective Tax Rate
9.69%14.38%10.30%
EBITDA
-35.24-22.26-20.15
EBITDA Margin
-643.22%-9120.90%-
EBIT
-35.72-22.71-20.53
EBIT Margin
-651.91%-9306.15%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).